Cost-per-responder analysis for eltrombopag and rituximab in the treatment of primary immune thrombocytopenia in Spain by Eduardo Anguita, Francisco Javier Parrondo García, José Ramón González-Porras

Get full text

Cost-effectiveness analysis of Belimumab in patients with systemic lupus erythematosus in Spain by Silvia Díaz-Cerezo, Ángel María García-Aparicio, Javier Parrondo, Laura Amanda Vallejo-Aparicio

Get full text

Matching-Adjusted Indirect Comparisons in the assessment of hemato-oncological drugs by Francisco Javier Parrondo-García, José Manuel Martínez-Sesmero, Javier De Castro-Carpeño, Araceli López-de las Heras, Alonso Fernández-Nistal

Get full text

Cost-utility analysis of the fixed-dose combination of dolutegravir/abacavir/lamivudine as initial treatment of HIV+ patients in Spain by Santiago Moreno Guillen, Juan Emilio Losa García, Juan Berenguer Berenguer, José Manuel Martínez Sesmero, Santiago Cenoz Gomis, Ruth Graefenhain, David Lopez Sanchez-Cambronero, Francisco Javier Parrondo Garcia

Get full text